Globe Life/$GL
1D1W1MYTD1Y5YMAX
Capital at risk
About Globe Life
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
- Ticker
- $GL
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 3,695
- Headquarters
- McKinney, United States
- Website
- home.globelifeinsurance.com
Globe Life Metrics
BasicAdvanced
$13B
11.08
$15.08
0.47
$1.20
0.79%
Price and volume
Market cap
$13B
Beta
0.47
52-week high
$191.55
52-week low
$127.85
Average daily volume
434K
Dividend rate
$1.20
Financial strength
Current ratio
0.795
Quick ratio
0.64
Long term debt to equity
0.512
Total debt to equity
0.557
Dividend payout ratio (TTM)
7.47%
Interest coverage (TTM)
11.70%
Profitability
EBITDA (TTM)
1,680.269
Gross margin (TTM)
33.91%
Net profit margin (TTM)
19.58%
Operating margin (TTM)
26.71%
Effective tax rate (TTM)
18.95%
Revenue per employee (TTM)
$1,680,000
Management effectiveness
Return on assets (TTM)
3.36%
Return on equity (TTM)
20.95%
Valuation
Price to earnings (TTM)
11.078
Price to revenue (TTM)
2.131
Price to book
2.14
Price to tangible book (TTM)
2.27
Price to free cash flow (TTM)
10.71
Free cash flow yield (TTM)
9.34%
Free cash flow per share (TTM)
15.596
Dividend yield (TTM)
0.72%
Forward dividend yield
0.79%
Growth
Revenue change (TTM)
5.24%
Earnings per share change (TTM)
20.23%
3-year revenue growth (CAGR)
5.45%
10-year revenue growth (CAGR)
4.87%
3-year earnings per share growth (CAGR)
19.09%
10-year earnings per share growth (CAGR)
13.24%
3-year dividend per share growth (CAGR)
11.53%
10-year dividend per share growth (CAGR)
8.11%
What the Analysts think about Globe Life
Analyst ratings (Buy, Hold, Sell) for Globe Life stock.
Analyst projections of the future price of Globe Life stock.
Bulls say / Bears say
Globe Life delivered 10% year-on-year growth in second-quarter net operating EPS and raised its 2026 guidance to $15.55–$15.95 per share. That combination suggests the core underwriting and investment model is still producing dependable earnings growth. (Globe Life)
The supplemental health business is becoming a stronger growth engine and diversifies the mature life franchise. Second-quarter health premiums rose 16%, led by 29% growth at United American, and management expects health premiums to grow 14–16% for 2026. (Globe Life)
Globe Life is converting earnings into shareholder value through buybacks while growing its capital base. It repurchased 1.1 million shares for $175 million in the second quarter, while book value per share increased 18% year on year to $78.18. (Globe Life)
Health premiums rose 16% in the second quarter, but the health underwriting margin fell to 23% of premium from 26% a year earlier. If claims pressure persists, the division’s rapid growth could add less profit than investors expect. (ROIC AI)
The SEC and DOJ investigations ended without enforcement action, but private shareholder litigation and other claims remain active. These cases could bring legal costs, management distraction and further reputational damage. (LegalClarity, Globe Life)
The planned reinsurance structure is not yet a guaranteed source of parent-company cash: further cessions and dividends depend on state and Bermuda regulatory approvals. Management indicated that meaningful additional dividends are expected from 2027, so the capital-flexibility benefit may take time or arrive later than hoped. (ROIC AI)
Data summarised monthly by Lightyear AI. Last updated on 25 Sept 2026.
Globe Life Financial Performance
Revenues and expenses
Globe Life Earnings Performance
Company profitability
Upcoming events
Globe Life News
AllArticlesVideos
Funds containing Globe Life
AllEURGBPUSD
Fund name | Fund size | $GL weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.51% |
SPDR S&P US Dividend Aristocrats€SPYD | €3.3B | 0.30% |
SPDR S&P US Dividend Aristocrats£USDV | £2.8B | 0.30% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.25% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.25% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.